Fujisawa Pharmaceutical Co Ltd, an in-Dept View of the Organizations Deals and Partnering Companies Over a Five Year Period
Posted on: Wednesday, 9 November 2005, 18:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c26804 ) has announced the addition of Fujisawa Pharmaceutical Co Ltd Deals Briefing to their offering
Description
Fujisawa Pharmaceutical Co Ltd Deals briefing provides an in-depth view of the 57 deals made by Fujisawa Pharmaceutical Co Ltd and its subsidiaries with 63 partnering companies between 2000 and 2005, in a clear and accessible PDF format.
Chapter 1: Company profile
An overview of the company, including contact details, a summary of business and partnering interests, and a review of management
Chapter 2: Financial data and deals overview
A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.
Chapter 3: Summary of deals
A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.
Chapter 4: List of deals
A detailed listing of all the company's deals and alliances announced between January 2000 and July 2005.
Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.
Scope
The report contains:
a brief company profile including subsidiary names
financial information where disclosed
a deals overview
specialized indexes including deals by partner company, subsidiary company, therapy focus and development stage
a detailed listing of the company's deals and alliances.
Key questions answered
Fujisawa Pharmaceutical Co Ltd Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:
identifying active partners
tracking competitor activity
benchmarking deals
comparing the finances of different deal types.
Fujisawa Pharmaceutical Co Ltd Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Fujisawa Pharmaceutical Co Ltd.
Forecasts, projections, market estimates
This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.
Who should buy the report
This report is essential reading for board and executive management, and individuals in:
business development
licensing/partnering
deal making
business strategy
marketing and promotion
distribution and manufacturing (including contract services).
Topics Covered
Introduction
About Partneringdesk Deals briefings
Chapter 1: Company profile
Chapter 2: Financial data and deals overview
Chapter 3: Summary of deals
Deals involving Fujisawa Pharmaceutical Co Ltd by partner company
Deals involving Fujisawa Pharmaceutical Co Ltd by subsidiary
Deals involving Fujisawa Pharmaceutical Co Ltd by therapy focus
Deals involving Fujisawa Pharmaceutical Co Ltd by development stage
Chapter 4: List of deals
Glossary
List of Tables
Table 2.1 Fujisawa Pharmaceutical Co Ltd financial summary
Table 2.2 Fujisawa Pharmaceutical Co Ltd deals by deal type
Table 2.3 Fujisawa Pharmaceutical Co Ltd deals by therapy focus
Table 2.4 Fujisawa Pharmaceutical Co Ltd deals by development stage
Table 2.5 Fujisawa Pharmaceutical Co Ltd deals by industry sector
Companies Mentioned
Fujisawa Healthcare
Klinge Pharma
Shizuoka Fujisawa Co Ltd
Toyama Fujisawa Co Ltd
For more information visit http://www.researchandmarkets.com/reports/c26804
Source: Business Wire
Related Articles
- Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent Litigation
- China Cablecom Holdings, Ltd. Reports First Half 2009 Financial Results
- Webcast Alert: Isis Pharmaceuticals' Second Quarter 2009 Financial Results Conference Call
- Remington Arms Company, Inc. Reports 2008 Unaudited Summary Financial Information
- Diplomats Member Signs Unique Advertising Deal With Philadelphia-Based Focus Entertainment
- U.S. Energy Systems, Inc. Reports Preliminary Summary Financial Results for First Half of 2007
- JSC SITRONICS Summary Financial Results for the Three Months Ended March 31, 2007
- United Therapeutics Announces Share Repurchase Program, Third Quarter 2006 Preliminary Summary Financial Results and Clinical Update
- North American Palladium Ltd. Announces First Quarter 2006 Financial Results
- PerkinElmer to Sell Off Units in Deals Worth $400m to Focus on Life Sciences
User Comments (0)

RSS Feeds